Commission Regulation (EU) 2023/198 of 30 January 2023 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for abamectin in or on certain products
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XIII Medicinal Products
Joint committee decision (JCD)
204/2023
In force in the EEA
Yes
Legal Documents
Commission Regulation (EU) 2023/198 of 30 January 2023 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for abamectin in or on certain products
Reglugerð framkvæmdastjórnarinnar (ESB) 2023/198 frá 30. janúar 2023 um breytingu á II. viðauka við reglugerð Evrópuþingsins og ráðsins (EB) nr. 396/2005 að því er varðar hámarksgildi leifa fyrir abamektín í eða á tilteknum afurðum
Verordnung (EU) 2023/198 der Kommission vom 30. Januar 2023 zur Änderung des Anhangs II der Verordnung (EG) Nr. 396/2005 des Europäischen Parlaments und des Rates hinsichtlich der Höchstgehalte an Rückständen von Abamectin in oder auf bestimmten Erzeugnissen
Kommisjonsforordning (EU) 2023/198 av 30. januar 2023 om endring av vedlegg II til europaparlaments- og rådsforordning (EF) nr. 396/2005 med hensyn til øvre grenseverdier for rester av abamektin i eller på visse produkter
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.